MTZ Clinical Research Sp. z o. o. (MTZ) is a leading Polish contract research organization. Our company has been operating since 2002 and specializes in early-phase clinical studies, bioavailabity and bioequivalence studies.

MTZ has its own Clinical Research Site with an intensive care room, registered medical analysis laboratory, laboratory for biological sample processing and a registered pharmacy for storage and preparation of study products, including oncological products.

MTZ Clinical Site also participates in Phase III studies as a highly specialized clinical research site.

In 2009 our company obtained ISO 9001:2008 certificate from DAS Certification Ltd. (accredited by UKAS), the certificate was confirmed in 2012.  It was awarded for the following scope of operations:

    • Conduct of contracted clinical trials

    • Operation of MTZ Clinical Research Site

During the last 10 years the company has undergone 40 international audits and an inspection conducted by the Polish Office for Registration of Medicinal Products, Medical Devices and Biocidal Products. MTZ has received positive evaluations in all the audits and  inspection.

Our company has conducted over 150 clinical trials on more than 6,000 subjects, both healthy volunteers and patients aged 18 to 75 years recruited mostly from our own registered database of subjects (www.ciekawebadania.pl).

Our company conducts clinical trials in compliance with the requirements of GCP, EMA and FDA.

MTZ has an experienced team of clinical trial experts and a network of professional partners providing services in the development of medicinal, cosmetic and food supplement products and medical devices.

Our customers include European, American and other international pharmaceutical and biotechnology companies, and contract research organizations (CRO).

MTZ is located in the Medical Research Centre of the Polish Academy of Sciences in Warsaw, Poland, Pawinskiego 5.

To top